槲皮素对四氯化碳致大鼠肝纤维化的缓解作用及其机制研究（英文）

槲皮素是一种广泛存在于蔬菜和水果中的酚类植物化学物质,具有抗氧化、抗炎、抗病毒和免疫调节活性,已成功应用于急慢性疾病的治疗。本研究目的是探讨槲皮素对大鼠肝纤维化的缓解作用并探讨其作用机制。将健康雄性SD大鼠随机分为正常组、模型组和槲皮素组,每组6只。通过腹腔注射1 m L/kg四氯化碳(50%v/v,溶于橄榄油),每周2次,持续6周诱导肝脏纤维化,并于第7周灌胃给予槲皮素(100mg/kg/d)持续至第12周结束。末次给药1h后,收集血液和肝脏样品。利用全自动生化仪检测血清肝功能参数(AST、ALT、ALP、GGT和TBA);HE、Masson和天狼星红染色观察肝组织病理形态;Westernblotting评价肝纤维化因子(TGF-β1、α-SMA、MMP2和MMP9)和胆汁酸相关调节蛋白(FXR、CYP7A1、CYP8B1和CYP27A1)的表达;采用试剂盒检测肝组织氧化应激标志物(GSH、GSH-Px、GR、SOD和MDA)的含量;运用LC-MS/MS测定肝组织中胆汁酸含量。结果发现与模型组相比,给予槲皮素治疗后可显著降低血清AST、ALT和TBA含量(P <0.05);肝纤...

The alleviating effect of quercetin on carbon tetrachloride-induced liver fibrosis in rats and its underlying mechanism

Quercetin, a phenolic phytochemical widely present in vegetables and fruits, has antioxidant, anti-inflammatory, antiviral, and immunomodulatory activities, and it has been successfully used in the treatment of acute and chronic diseases. In the present study, we aimed to investigate the alleviation effect of quercetin on rat liver fibrosis and explore its mechanism of action. Healthy male SD rats were randomly divided into the normal group, model group, and quercetin group, with six rats in each group. Liver fibrosis was induced by intraperitoneal injection of 1 mL/kg carbon tetrachloride (50% v/v in olive oil) twice a week for 6 weeks, and quercetin (100 mg/kg/d) was administered orally in the 7th week until the end of the 12th week. Blood and liver samples were collected at 1 h after the last administration. Serum liver function parameters (AST, ALT, ALP, GGT, and TBA) were detected by an automatic biochemical analyzer. H&E, Masson, and Sirius red staining were used to observe the pathological morphology of liver tissue. Western blotting analysis was used to evaluate the expressions of liver fibrotic factors (TGF-β1, α-SMA, MMP2, and MMP9) and bile acid-related regulatory proteins (FXR, CYP7A1, CYP8B1, and CYP27A1). The oxidative stress markers (GSH, GSH-Px, GR, SOD, and MDA) in the liver tissue were detected using corresponding kits. The contents of bile acids in the liver tissue were determined by LC-MS/MS. The results showed that compared with the model group, quercetin treatment could significantly reduce serum AST, ALT, and TBA levels (P < 0.05). The fibrotic liver injury was significantly improved, and the expressions of fibrotic factors TGF-β1, α-SMA, MMP2, and MMP9 were significantly decreased (P < 0.05). Liver GSH, GSH-Px, GR, and SOD levels were significantly increased (P < 0.05), and the MDA level was significantly decreased (P < 0.05). The contents of hepatic bile acids were significantly decreased (P < 0.05), the expression of FXR was significantly increased (P < 0.05), and the expressions of CYP7A1 and CYP8B1 were significantly decreased (P < 0.05). This study suggested that quercetin could effectively alleviate carbon tetrachloride-induced liver fibrosis injury, and its mechanism of action was related to improving the liver’s ability to resist oxidative stress and reducing the expressions of fibrotic factors and bile acid synthesis.